Navigation Links
Sinapis Pharma To Present at Rodman & Renshaw Conference
Date:9/8/2009

JACKSONVILLE, Fla., Sept. 8 /PRNewswire/ -- Sinapis Pharma announces that it will present an overview of its stroke and traumatic brain injury treatment data at the Rodman & Renshaw Annual Global Investment Conference at the Palace Hotel in New York City this Friday, September 11, 2009, at 3:15 PM ET. Sinapis has discovered and has patents-pending for a novel use and route of administration of an FDA-approved drug that will be in clinical development in the near future. Further information can be found at www.sinapispharma.com or the conference website www.rodmanandrenshaw.com/conferences.


'/>"/>
SOURCE Sinapis Pharma, Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. FDA pharmaceutical import alert
2. Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma
3. KV Pharmaceutical Appoints Interim Chief Financial Officer
4. Prodigy AutoCode Now Available in 116 Harris Teeter Pharmacies
5. Pharmacists Urge the Public to Begin Getting Immunized
6. Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
7. Jazz Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program
10. Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program
11. Americas No. 1 Pharmacy Names Great Health as Its Exclusive Health and Wellness Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp ... in and around the greater Phoenix metropolitan region, is announcing a charity event ... mission of the Homeless Youth Connection is to promote community awareness of the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, ... residential and commercial clients in the northern Alabama and Georgia regions, is embarking ... Since 1977, Nobis Works has built a network of support and education facilities ...
(Date:12/7/2016)... ... December 07, 2016 , ... Students attending Envision’s ... unique opportunity to get hands-on experience in an emergency medical simulation, When Care ... to gain invaluable, real-life medical skills that are critical success in a future ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the drug in their bodies, a researcher at the Icahn School of Medicine ... Research. , The study found that when young children are exposed to secondhand ...
(Date:12/7/2016)... PHILADELPHIA, PA (PRWEB) , ... December 07, 2016 ... ... story of a women growing up with a schizophrenic mother in a unique, ... social worker who specializes in treating trauma and addictive disorders at her private ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... YORK , December 8, 2016 ... focused on the research, distribution, and marketing of pharmaceutical ... affected by patent protection and expiration. Additionally, these firms ... Healthcare sector as a whole. Up for review this ... ), Synergy Pharmaceuticals Inc. (NASDAQ: SGYP ), ...
(Date:12/8/2016)... DES MOINES, Iowa , Dec. 8, 2016 ... STLT), a pharmaceutical company advancing technologies designed to ... the appointment of Chitra Edwin , Ph.D., ... and Compliance. Dr. Edwin will provide leadership for ... planning for regulatory approvals, preparation of regulatory submissions, ...
(Date:12/7/2016)... , Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial ... 37 biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar ... Japan , Kenya , ... , China , Slovakia , ... & 2 diabetes mellitus. The patent on Lantus expired in 2014. ...
Breaking Medicine Technology: